• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ABC途径对高龄中国房颤患者临床结局的影响。来自中国老年房颤患者最佳血栓预防(ChiOTEAF)注册研究的报告。

Effects of the ABC pathway on clinical outcomes in very elderly Chinese patients with atrial fibrillation. A report from the optimal thromboprophylaxis in elderly Chinese patients with atrial fibrillation (ChiOTEAF) registry.

作者信息

Fawzy Ameenathul Mazaya, Kotalczyk Agnieszka, Guo Yutao, Wang Yutang, Lip Gregory Y H

机构信息

Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom.

Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia, Silesian Centre for Heart Diseases, Zabrze, Poland.

出版信息

Intern Emerg Med. 2025 Apr 27. doi: 10.1007/s11739-025-03928-0.

DOI:10.1007/s11739-025-03928-0
PMID:40287919
Abstract

The current Atrial fibrillation Better Care (ABC) pathway for holistic or integrated management of AF is associated with improved clinical outcomes; however, data on the very elderly (aged ≥ 85 years) are sparse.To evaluate the impact of ABC pathway on clinical outcomes amongst very elderly AF patients over a follow-up period of 1 year.The ChiOTEAF registry is a prospective, multicenter nationwide study conducted from October 2014 to December 2018. Endpoints of interest were the composite outcome of all-cause death/any thromboembolism (TE), all-cause death, TE events, and major bleeding.The eligible cohort included 1215 individuals (mean age 88.5 ± 3.3; 33.5% female), of which 142 (11.7%) were managed accordingly to the ABC pathway. ABC compliance was independently associated with lower odds of the composite outcome (odds Ratio (OR): 0.23; 95% confidence interval (CI): 0.08-0.66) and all-cause death (OR: 0.22; 95% CI: 0.07-0.75), without a significant increase in major bleeding compared to ABC non-compliance. Health-related quality of life (QOL) was also significantly higher in the ABC compliant group compared to the non-compliant group (EQ score 0.83 ± 0.17 vs. 0.78 ± 0.20; p =  0.004). Independent predictors of ABC non-compliance were prior major bleeding, chronic kidney disease, and dementia.Our findings suggest that adherence to the ABC pathway in very elderly patients is associated with significantly improved survival and health-related QOL.

摘要

目前用于心房颤动(AF)整体或综合管理的心房颤动更佳护理(ABC)路径与改善临床结局相关;然而,关于高龄(≥85岁)患者的数据却很稀少。为了评估ABC路径对高龄AF患者在1年随访期内临床结局的影响。ChiOTEAF注册研究是一项于2014年10月至2018年12月进行的前瞻性、多中心全国性研究。感兴趣的终点是全因死亡/任何血栓栓塞(TE)、全因死亡、TE事件和大出血的复合结局。符合条件的队列包括1215名个体(平均年龄88.5±3.3岁;33.5%为女性),其中142名(11.7%)按照ABC路径进行管理。ABC依从性与复合结局的较低几率(优势比(OR):0.23;95%置信区间(CI):0.08 - 0.66)和全因死亡(OR:0.22;95%CI:0.07 - 0.75)独立相关,与未依从ABC相比,大出血没有显著增加。与未依从组相比,ABC依从组的健康相关生活质量(QOL)也显著更高(EQ评分0.83±0.17 vs. 0.78±0.20;p = 0.004)。ABC不依从的独立预测因素是既往大出血、慢性肾病和痴呆。我们的研究结果表明,高龄患者坚持ABC路径与生存和健康相关QOL的显著改善相关。

相似文献

1
Effects of the ABC pathway on clinical outcomes in very elderly Chinese patients with atrial fibrillation. A report from the optimal thromboprophylaxis in elderly Chinese patients with atrial fibrillation (ChiOTEAF) registry.ABC途径对高龄中国房颤患者临床结局的影响。来自中国老年房颤患者最佳血栓预防(ChiOTEAF)注册研究的报告。
Intern Emerg Med. 2025 Apr 27. doi: 10.1007/s11739-025-03928-0.
2
Anticoagulants for people hospitalised with COVID-19.COVID-19 住院患者的抗凝治疗。
Cochrane Database Syst Rev. 2022 Mar 4;3(3):CD013739. doi: 10.1002/14651858.CD013739.pub2.
3
Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias.心律失常成人患者行导管消融术时,中断与不中断抗凝治疗的比较。
Cochrane Database Syst Rev. 2021 Oct 21;10(10):CD013504. doi: 10.1002/14651858.CD013504.pub2.
4
Antithrombotic treatment after stroke due to intracerebral haemorrhage.脑出血所致脑卒中后的抗血栓治疗。
Cochrane Database Syst Rev. 2023 Jan 26;1(1):CD012144. doi: 10.1002/14651858.CD012144.pub3.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.老年新诊断胶质母细胞瘤的治疗:一项网状Meta分析
Cochrane Database Syst Rev. 2020 Mar 23;3(3):CD013261. doi: 10.1002/14651858.CD013261.pub2.
7
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.心房颤动和典型心房扑动的根治性导管消融术:系统评价与经济评估
Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340.
8
Direct-acting antivirals for chronic hepatitis C.用于慢性丙型肝炎的直接作用抗病毒药物。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence.全身性皮质类固醇治疗 COVID-19:与公平相关的分析和证据更新。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD014963. doi: 10.1002/14651858.CD014963.pub2.

本文引用的文献

1
The 2024 European Society of Cardiology Guidelines for Diagnosis and Management of Atrial Fibrillation: A Viewpoint from a Practicing Clinician's Perspective.2024 年欧洲心脏病学会心房颤动诊断和管理指南:临床医生视角。
Thromb Haemost. 2024 Dec;124(12):1087-1094. doi: 10.1055/a-2434-9244. Epub 2024 Oct 7.
2
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).2024年欧洲心脏病学会(ESC)心房颤动管理指南,与欧洲心胸外科学会(EACTS)联合制定。
Eur Heart J. 2024 Sep 29;45(36):3314-3414. doi: 10.1093/eurheartj/ehae176.
3
2024 Chinese Expert Consensus Guidelines on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly, Endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular Branch): Executive Summary.
2024 年中国老年医学学会老年心血管病分会、中华医学会老年医学分会心血管病学组《老年心房颤动诊断与治疗中国专家共识(2024)》概要。
Thromb Haemost. 2024 Oct;124(10):897-911. doi: 10.1055/a-2325-5923. Epub 2024 May 14.
4
Racial Differences in Ischemic and Hemorrhagic Stroke: An Ecological Epidemiological Study.种族差异与缺血性卒中和出血性卒中:一项生态流行病学研究。
Thromb Haemost. 2024 Sep;124(9):883-892. doi: 10.1055/a-2278-8769. Epub 2024 Feb 29.
5
Racial Differences in Bleeding Risk: An Ecological Epidemiological Study Comparing Korea and United Kingdom Subjects.种族间出血风险的差异:一项比较韩国和英国人群的生态流行病学研究。
Thromb Haemost. 2024 Sep;124(9):842-851. doi: 10.1055/a-2269-1123. Epub 2024 Feb 15.
6
Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial Fibrillation.心房颤动优化照护路径依从性照护可改善中国心房颤动患者的结局。
JACC Asia. 2022 Apr 26;2(4):422-429. doi: 10.1016/j.jacasi.2022.01.007. eCollection 2022 Aug.
7
Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation: A Prespecified Subanalysis of the ELDERCARE-AF Randomized Clinical Trial.15 毫克依度沙班对老年房颤患者 3 个年龄亚组临床结局的影响:ELDERCARE-AF 随机临床试验的预设亚组分析。
JAMA Cardiol. 2022 Jun 1;7(6):583-590. doi: 10.1001/jamacardio.2022.0480.
8
Effects of the Atrial Fibrillation Better Care Pathway on Outcomes Among Clinically Complex Chinese Patients With Atrial Fibrillation With Multimorbidity and Polypharmacy: A Report From the ChiOTEAF Registry.《房颤优化管理路径对伴有多种合并症和多种药物治疗的临床复杂中国房颤患者结局的影响:来自 ChiOTEAF 登记研究的报告》。
J Am Heart Assoc. 2022 Apr 5;11(7):e024319. doi: 10.1161/JAHA.121.024319. Epub 2022 Apr 4.
9
Barriers to prescribing oral anticoagulants to inpatients aged 80 years and older with nonvalvular atrial fibrillation: a cross-sectional study.80 岁及以上非瓣膜性心房颤动住院患者口服抗凝剂处方障碍:一项横断面研究。
BMC Geriatr. 2022 Mar 30;22(1):263. doi: 10.1186/s12877-022-02965-0.
10
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.2021 年亚太心律学会心房颤动卒中预防聚焦更新共识指南:执行摘要。
Thromb Haemost. 2022 Jan;122(1):20-47. doi: 10.1055/s-0041-1739411. Epub 2021 Nov 13.